Fight Colorectal Cancer Heads to Minnesota for Pitch for Prevention

By: Advocate · July 18, 2014 ·

FOR IMMEDIATE RELEASE National March Against Colorectal Cancer Heads to Minnesota Twins’ Target Field for Pitch for Prevention Fight Colorectal Cancer’s coast-to-coast colorectal cancer awareness campaign, One Million Strong, is collaborating with Mayo Clinic and prostate cancer group Ed Randall’s… Read More

Avastin Users Wanted for New Research Study

Fight Colorectal Cancer is partnering together with 23andme and Genentech to help researchers better understand if patients’ genes play a role in how they respond to treatments they receive for their colorectal cancer. This provides patients a new opportunity to… Read More

Fake Avastin Discovered in US

The Food and Drug Adminstration and Genentech have reported that counterfeit Avastin is being distributed in the United States. The counterfeit medicine does not contain bevacizumab, Avastin’s active ingredient. The packaging is different from genuine Avastin marketed here by Genentech.… Read More

C-08 Avastin Trial Didn't Meet Primary Goal

When Avastin® (bevacizumab) was added to standard chemotherapy after surgery, it didn’t reduce the risk that early stage colon cancer would return, according to a press release this morning from Genentech. NSABP C-08 randomly assigned patients with stage II or III colon cancer… Read More